IL23A, Human (Tildrakizumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.

Search, find, compare suppliers for anti-IL23A, Human (Tildrakizumab biosimilar) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityIL23A, Human (Tildrakizumab biosimilar)
CloneTildrakizumab
Host SpeciesRecombinant Mouse
Reactive Specieshuman
IsotypeIgG1 kappa
Formatpurified
Size1mg, 5mg
Concentration1mg/ml
ApplicationsNeut, ELISA, IF, IP, FuncS, FCM, ICC
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionAnti-Human IL23A Recombinant Antibody (Tildrakizumab). Tildrakizumab (trade name Ilumya (US)/Ilumetri (European Union)) is a monoclonal antibody designed for the treatment of immunologically mediated inflammatory disorders. It is approved for the treatment of adult patients with moderate-to-severe plaque psoriasis in the United States and the European Union.
Immunogenn/a
Other NamesAnti-IL23A Recombinant Antibody, Research Grade Tildrakizumab, Anti-Human IL23A Recombinant Antibody(Tildrakizumab), MK-3222, SCH900222, Antibody Drug Analogues, Monoclonal Antibody, YR1295, Research Grade Biosimilars, Biosimilar Antibody
Gene, Accession #CAS: 1326244-10-3
Catalog #YR1295
Priceplease inquire
Order / More InfoIL23A, Human (Tildrakizumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.
Product Specific Referencesn/a
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
FL-4, Building A5
International Enterprise Community
Tianjin CHINA
P: 400-621-6806

info@kmdbioscience.com
Sales: sales@kmdbiosci.com

https://www.kmdbioscience.com

Profile of KMD BIOSCIENCE CO. LTD.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.